Featured Information

  • Clinical Cytometry Journal article highlights and evaluates the PointCare NOW as a leader in meeting the requirements of affordable CD4 T-Cell enumeration for resource-limited regions.

  • Read this presentation by Dr Tom Spira of the CDC suggesting higher standards for external validation protocols of CD4 and Viral Load Assays.

  • Looking for an introduction to CD4 enumeration in the context of HIV/AIDS? The WHO guidelines cover key HIV therapy, flow cytometry, and clinical and instrumentation considerations.

In your local clinicBefore - after timely therapy
In your mobile clinicIn your laboratory

PointCare · Diagnostics for the People

July 01, 2008

PointCare uses World Bank grant to establish CD4/CD4% testing in Malawi
Read More

June 30, 2008

PointCare NOW: Reports from the Field
Read More

June 15, 2008

FDA approval for PointCare NOW
Read More

June 01, 2008

PointCare Technologies Announces the PointCare NOW, Bringing HIV/AIDS Diagnostics to the People
Read More

April 24, 2008

Brook Venture Fund II Leads $3.6M Investment In PointCare Technologies, Inc.
Read More

Universal access to diagnostics, especially in
resource-limited urban and rural environments

At PointCare, we believe in a universal right of access to quality medical care, no matter where a person lives. Creating robust and simple-to-use diagnostic technology is an essential part of satisfying this basic right, particularly for those living in resource-limited urban and rural environments. Our goal is to apply innovative scientific technology to meet the challenges of decentralised diagnostics and treatment.  Join our vision today for global access to healthcare without compromise in quality, and enjoy the simplicity of the diagnostic care products provided by PointCare.